|
1
|
Azubuike SO, Muirhead C, Hayes L and
McNally R: Rising global burden of breast cancer: The case of
sub-Saharan Africa (with emphasis on Nigeria) and implications for
regional development: A review. World J Surg Oncol.
16(63)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Heer E, Harper A, Escandor N, Sung H,
McCormack V and Fidler-Benaoudia MM: Global burden and trends in
premenopausal and postmenopausal breast cancer: A population-based
study. Lancet Glob Health. 8:e1027–e1037. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ali-Gombe M, Mustaph MI, Folasire A,
Ntekim A and Campbell OB: Pattern of survival of breast cancer
patients in a tertiary hospital in south west Nigeria.
Ecancermedicalscience. 15(1192)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hung MC, Ekwueme DU, Rim SH and White A:
Racial/ethnicity disparities in invasive breast cancer among
younger and older women: An analysis using multiple measures of
population health. Cancer Epidemiol. 45:112–118. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
El Saghir NS, Khalil LE, El Dick J, Atwani
RW, Safi N, Charafeddine M, Al-Masri A, El Saghir BN, Chaccour M,
Tfayli A, et al: Improved survival of young patients with breast
cancer 40 years and younger at diagnosis. JCO Glob Oncol.
9(e2200354)2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Reed BG and Carr BR: The normal menstrual
cycle and the control of ovulation. In: Feingold KR, ASF AB (eds)
et al. Endotext. 2nd edition. South Dartmouth (MA):
MDText.com, Inc.; 2018.
|
|
7
|
Delamater L and Santoro N: Management of
the perimenopause. Clin Obstet Gynecol. 61:419–432. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Davis SR, Pinkerton J, Santoro N and
Simoncini T: Menopause-Biology, consequences, supportive care, and
therapeutic options. Cell. 186:4038–4058. 2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Partridge AH, Gelber S, Peppercorn J,
Sampson E, Knudsen K, Laufer M, Rosenberg R, Przypyszny M, Rein A
and Winer EP: Web-based survey of fertility issues in young women
with breast cancer. J Clin Oncol. 22:4174–4183. 2004.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hong YH, Park C, Paik H, Lee KH, Lee JR,
Han W, Park S, Chung S and Kim HJ: Fertility preservation in young
women with breast cancer: A review. J Breast Cancer.
26(221)2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mannion S, Higgins A, Larson N, Stewart
EA, Khan Z, Shenoy C, Nichols HB, Su HI, Partridge AH, Loprinzi CL,
et al: Prevalence and impact of fertility concerns in young women
with breast cancer. Sci Rep. 14(4418)2024.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Turnbull AK, Patel S, Martinez-Perez C,
Rigg A and Oikonomidou O: Risk of chemotherapy-related amenorrhoea
(CRA) in premenopausal women undergoing chemotherapy for early
stage breast cancer. Breast Cancer Res Treat. 186:237–245.
2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sun M, Liu C, Zhang P, Song Y, Bian Y, Ke
S, Lu Y and Lu Q: Perspectives and needs for fertility preservation
decision-making in childbearing-age patients with breast cancer: A
qualitative study. Asia Pac J Oncol Nurs. 11(100548)2024.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Letourneau JM, Ebbel EE, Katz PP, Oktay
KH, McCulloch CE, Ai WZ, Chien AJ, Melisko ME, Cedars MI and Rosen
MP: Acute ovarian failure underestimates age-specific reproductive
impairment for young women undergoing chemotherapy for cancer.
Cancer. 118:1933–1939. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lambert-Messerlian G, Plante B, Eklund EE,
Raker C and Moore RG: Levels of antimüllerian hormone in serum
during the normal menstrual cycle. Fertil Steril. 105:208–213.
2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Furlanetto J, Marmé F, Seiler S, Thode C,
Untch M, Schmatloch S, Schneeweiss A, Bassy M, Fasching PA, Strik
D, et al: Chemotherapy-induced ovarian failure in young women with
early breast cancer: Prospective analysis of four randomised
neoadjuvant/adjuvant breast cancer trials. Eur J Cancer.
152:193–203. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Soewoto W and Agustriani N: Estradiol
levels and chemotherapy in breast cancer patients: A prospective
clinical study. World J Oncol. 14:60–66. 2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bala J, Seth S, Dhankhar R and Ghalaut VS:
Chemotherapy: Impact on Anti-Müllerian Hormone Levels in Breast
Carcinoma. J Clin Diagn Res. 10:BC19–BC21. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kevenaar ME, Meerasahib MF, Kramer P, van
de Lang-Born BMN, de Jong FH, Groome NP, Themmen AP and Visser JA:
Serum anti-mullerian hormone levels reflect the size of the
primordial follicle pool in mice. Endocrinology. 147:3228–3234.
2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zong X, Yu Y, Chen W, Zong W, Yang H and
Chen X: Ovarian reserve in premenopausal women with breast cancer.
Breast. 64:143–150. 2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Malisic E, Susnjar S, Milovanovic J,
Todorovic-Rakovic N and Kesic V: Assessment of ovarian function
after chemotherapy in women with early and locally advanced breast
cancer from Serbia. Arch Gynecol Obstet. 297:495–503.
2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yu B, Lobo R, Crew K, Ferin M, Douglas N,
Nakhuda G and Hershman D: Predictive markers of
chemotherapy-induced menopause in premenopausal women under the age
of 40 with breast cancer. Cancer Res. 69 (2_Suppl)(S1118)2009.
|
|
23
|
Moore HCF, Unger JM, Phillips KA, Boyle F,
Hitre E, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS,
et al: Goserelin for ovarian protection during breast-cancer
adjuvant chemotherapy. N Engl J Med. 372:923–932. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wong M, O'Neill S, Walsh G and Smith IE:
Goserelin with chemotherapy to preserve ovarian function in
pre-menopausal women with early breast cancer: Menstruation and
pregnancy outcomes. Ann Oncol. 24:133–138. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Cerminaro RM, Gardner HM, Shultz SJ,
Dollar JM, Wideman L and Duffy DM: The accuracy of early
reproductive history and physical activity participation recall
across multiple age ranges. J Womens Health (Larchmt). 32:715–722.
2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Pourali L, Taghizadeh Kermani A,
Ghavamnasiri MR, Khoshroo F, Hosseini S, Asadi M and Anvari K:
Incidence of chemotherapy-induced amenorrhea after adjuvant
chemotherapy with taxane and anthracyclines in young patients with
breast cancer. Iran J Cancer Prev. 6:147–150. 2013.PubMed/NCBI
|
|
27
|
Obadipe J, Samuel T, Akinlalu A, Ajisafe
A, Olajide E and Albdulmumin L: Chemotherapy-induced ovarian
toxicity in female cancer patients from selected nigerian tertiary
health care. Niger J Exp Clin Biosci. 9(89)2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Goldfarb SB, Bedoschi G, Turan V, Crown A,
Abdo N, Dickler MN and Oktay K: Impact of breast cancer
chemotherapy on ovarian damage and recovery. J Clin Oncol. 38
(15_suppl)(e24059)2020.
|
|
29
|
Coburn SB, Dionne-Odom J, Alcaide ML,
Moran CA, Rahangdale L, Golub ET, Massad LS, Seidman D, Michel KG,
Minkoff H, et al: The association between HIV status, estradiol,
and sex hormone binding globulin among premenopausal women in the
women's interagency HIV study. J Womens Health (Larchmt).
31:183–193. 2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Mauri D, Gazouli I, Zarkavelis G, Papadaki
A, Mavroeidis L, Gkoura S, Ntellas P, Amylidi AL, Tsali L and
Kampletsas E: Chemotherapy associated ovarian failure. Front
Endocrinol (Lausanne). 11(572388)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ben-Aharon I, Granot T, Meizner I, Rizel
S, Yerushalmi R, Sulkes A and Stemmer SM: Chemotherapy-induced
ovarian failure in young breast cancer patients: The role of
vascular toxicity. J Clin Oncol. 32(15_suppl)(S9595)2014.
|
